J.P. Morgan Reiterates Overweight Rating On Covidien

According to J.P. Morgan, Covidien (NYSE: COV) Overweight rating is reiterated.

J.P. Morgan reported that the 2011 SAGES meeting is underway in San Antonio. “In the Endo-Mechanical markets, J&J has stolen the headlines at this year's meeting, introducing the first power stapler, while Covidien continues to roll out Tri-Staple and a series of high impact products from last year's meeting.”

Covidien closed yesterday at $51.94.